ADIPOQ and familial pancreatic carcinoma: With regard to pancreatic cancer, we demonstrated that the effects of adiponectin and AdipoRon on cancer cells were partially due to suppression of the STAT3 signaling pathway as well as AMPK-pathway activation resulting in decreased proliferation [10, 11].